About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Anti-histamines and Methacholine Challenges.

NCT01985789·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Don Cockcroft

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Baseline forced expiratory volume in 1s (FEV1) of 70% or more of predicted
Methacholine provocative concentration causing a 20% fall in FEV1 16mg/ml or less
No respiratory infection or change in allergen exposure for 4 weeks prior to screening and throughout the study
No significant medical co-morbidities
allergy

You may not be if

pregnant or breastfeeding females
unable to withhold antihistamines, anticholinergics, long acting bronchodilators and combination therapies

The record

StatusCompleted

PhasePhase 4

Taking part12

StartedNov 2013

UpdatedApr 8, 2015

Conditions

Where1

University of Saskatchewan
Saskatoon, Saskatchewan, Canada

Clareo Health | Anti-histamines and Methacholine Challenges.